Your session is about to expire
← Back to Search
Imaging
Screening Methods for Liver Cancer
N/A
Waitlist Available
Led By Jessica P Hwang
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must be at least 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights
Summary
This trial is testing a new way to screen for liver fibrosis and cirrhosis. It may help improve survival for patients with liver cancer.
Who is the study for?
This trial is for adults over 18 who can speak and read English or another language with available translation at the HOPE clinic. It's open to new or current patients seeking regular care at the clinic, but pregnant individuals cannot participate.
What is being tested?
The study is testing how well surveys, blood tests, and a liver scan called Fibroscan can screen for liver fibrosis and cirrhosis in patients. The goal is to find better ways to detect liver cancer early on in people getting care at the HOPE clinic.
What are the potential side effects?
There are minimal side effects expected from this trial as it involves non-invasive procedures like surveys, blood tests, and Fibroscan (similar to an ultrasound). However, some discomfort may occur during blood collection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Positive hepatitis B surface antigen test result
Secondary study objectives
Fibroscan result >= F2
Positive anti-hepatitis C virus (HCV) test result
Trial Design
1Treatment groups
Experimental Treatment
Group I: Screening (survey, biomarker analysis, fibroscan)Experimental Treatment4 Interventions
Patients complete surveys over 10-15 minutes, and undergo blood testing, clinical evaluation, and fibroscan at baseline.
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
3,039 Previous Clinical Trials
1,798,701 Total Patients Enrolled
22 Trials studying Liver Cancer
9,411 Patients Enrolled for Liver Cancer
Cancer Prevention Research Institute of TexasOTHER
52 Previous Clinical Trials
97,960 Total Patients Enrolled
2 Trials studying Liver Cancer
68 Patients Enrolled for Liver Cancer
Jessica P HwangPrincipal InvestigatorM.D. Anderson Cancer Center
3 Previous Clinical Trials
2,258 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Screening (survey, biomarker analysis, fibroscan)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger